• Seventeen lectures and 9 workshop sessions
• Presentation slides with synchronized audio
• Downloadable PDFs of course content
• Watch presentations on your computer, tablet, or smart phone.
• Earn up to 29.25 CME credits and MOC points

1. Describe the current guidelines related to evaluation and management of patients with cardiac rhythm disturbances
2. Describe the role of electrophysiologic testing in managing patients with bradyarrhythmias and tachyarrhythmias
3. Identify the advantages and limitations of diagnostic electrophysiologic methods
4. Identify the role of pharmacologic and nonpharmacologic therapies for the treatment of arrhythmias
5. Recognize the basic electrophysiology and genetics of inherited conditions associated with cardiac arrhythmias
6. Recognize clinical, electrocardiographic, and electrophysiologic characteristics of specific cardiac arrhythmia syndromes
7. Interpret complex electrophysiologic and electrocardiographic tracings
8. Interpret stored electrograms from pacemakers and ICDs

Session I: Basic Science and Fundamentals of Electrophysiology
Basic Electrophysiology Principles for the Clinician
Inherited Ion Channelopathies
Sinoatrial and Atrioventricular Nodes and His-Purkinje System: Anatomy, Evaluation, Autonomics and Therapy
Retrograde Conduction
Workshop #1: Electrocardiographic/Electrophysiologic Correlations

Session II: Invasive Diagnosis and Treatment
Use of Entrainment in Supraventricular Tachycardia
Principles of Entrainment – Ventricular Tachycardia
Techniques of Differentiating SVT Mechanisms: Part I
Techniques of Differentiating SVT Mechanisms: Part II
Workshop #2: Entrainment and SVT Maneuvers
Catheter Ablation of Atrial Tachycardia and Atrial Flutter
Catheter Ablation of Accessory Pathways
Workshop #3: SVT Mechanisms/Maneuvers
Catheter Ablation of AV Nodal Reentrant Tachycardia
Special Workshop: 12 Lead EKG for PVC and VT Localization Core Principles of Electrophysiology

Session III: Invasive Diagnosis and Treatment
Ventricular Tachycardia: Ischemic and Nonischemic Cardiomyopathy and Other Unique VT Syndromes
Workshop #4: SVT and VT Invasive/Noninvasive Correlation
Wide Complex Tachycarias: Idopathic VTs, Bundle Branch Reentry, Antidromic Tachycarias, Mechanisms, Electrocardiographic Manifestations, Invasive Assessment, and Ablation
Workshop #5: Invasive/Noninvasive Correlation

Session IV: Noninvasive Diagnosis and Treatment
Pharmacokinetics, Pharmacodynamics, Pharmacogenetics, and Clinical Electrophysiology of Anti-arrhythmic Drugs: Parts I & II
Workshop #6: Electrocardiographic/Electrophysiological Correlations
Mechanisms, Pharmacologic, and Non-pharmacologic Treatment of Atrial Fibrillation
Biophysics of Catheter Ablation
Workshop #7: Electrocardiographic/Electrophysiological Correlations, Atrial Fibrillation, Clinical Scenarios, and Syndromes

Session V: Clinical Scenarios/Device Management
Device: Evaluation, Management, and Troubleshooting
Workshop #8: Device Cases
Workshop #9: Arrhythmia Case Studies/Putting It All Together for the Boards
Testable Concepts

It is the policy of the Heart Rhythm Society to ensure balance, independent objectivity, and scientific rigor in all its certified educational activities. The Heart Rhythm Society adheres to the Standards for Commercial Support (SCS) of the Accreditation Council for Continuing Medical Education (ACCME) which requires that those individuals in a position to control the content of an educational activity (including planners, faculty, authors, committee members, content reviewers, editors, and staff) disclose all relevant* financial relationships (for self and for spouse/partner) with an ACCME-defined commercial interest** within the 12 months prior to the disclosure.

Any individual who refuses to disclose financial relationships will be disqualified from participating in HRS educational activities. Employees of ACCME-defined commercial interests can have no role in the planning or implementation of CME activities related to their products or services without a special exception from the HRS Senior Vice President for Education that will be granted only in specific circumstances that meet ACCME requirements.

Relevant Financial Relationships

*Relevant financial relationships are financial relationships in any amount, which occurred in the twelve-month period preceding the time that the individual was asked to assume a role controlling content of the CME activity, and which relate to the content of the educational activity, causing a conflict of interest. The ACCME considers financial relationships to create conflicts of interest in CME when individuals have both a financial relationship with a commercial interest and the opportunity to affect the content of CME about the products or services of that commercial interest.

**a commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests - unless the provider of clinical service is owned, or controlled by, an ACCME-defined commercial interest.

COI Resolution

For all accredited education activities, disclosures are reviewed for potential conflict of interest (COI) and conflicts resolved prior to the activity.  If conflicts are identified, the conflict may be resolved by one of the following COI resolution mechanisms:

• Replace the presenter
• Assign different content to presenter to avoid conflict of interest
• Limit the presentation to report without recommendations
• Utilize peer review of content prior to the program
• Require the faculty member to limit sources of recommendations to evidence-based research

FACULTY DISCLOSURES 

Samuel J. Asirvatham, M.D

Honoraria/Speaking/Consulting Fee: Boston Scientific Corp., BIOTRONIK, Medtronic, Inc., Abbott Laboratories.

Intellectual Property Rights: AliveCor

Kenneth A. Ellenbogen, MD, FHRS

Compensation for Services: Biosense Webster, Medtronic

Fellowship Support: Boston Scientific, Medtronic, Biotronik, Abbott: Honoraria, Lectures, Consulting.

Edward Paul Gerstenfeld, MD, FHRS

Compensation for Services: Medtronic, Inc., Boston Scientific Corp., St. Jude Medical, Boehringer Ingelheim.

Equity Interests/Stock Options – Non-Public: Rhythm Diagnostic Systems Inc.

Research Grants: St. Jude Medical, Biosense Webster, Inc.

Fellowship Support: Medtronic, Inc., Boston Scientific Corp., Biotronik, Biosense Webster, Inc.

Barry London, MD, PhD

Nothing Relevant to Disclose

Francis E. Marchlinski, MD, FHRS

Compensation for Advisory/Consulting Services: Biosense Webster, Inc., Abbott, Boston Scientific Corp., Medtronic, Inc., BIOTRONIK.

Research Grants: Medtronic, Inc., Boston Scientific Corp., BIOTRONIK, Abbott, Biosense Webster. 

Fellowship Support: BIOTRONIK, Boston Scientific Corp., Medtronic, Inc., Abbott, Biosense Webster.

Gregory F. Michaud, MD, FHRS

Nothing Relevant to Disclose

William M Miles, MD, FHRS

EP Fellowship support: Abbott, Biosense-Webster, Biotronic, Boston Scientific, Medtronic

Consultant: Medtronic, Inc.

John M. Miller, MD, FHRS

Compensation for Services: Medtronic, Inc., Boston Scientific Corp., Biosense Webster, Inc., BIOTRONIK, Topera Medical

Consulting Fees/Honoraria: Abbott Electrophysiology/Topera Medical, Biotronik, Boston Scientific Corp., Biosense Webster, Inc., Medtronic, Inc.

Fellowship Support: Medtronic, Inc., Boston Scientific Corp., Biosense Webster, Inc., Biotronik, Inc.

Jeanne E. Poole, MD, FHRS

Consulting Fees/Honoraria: Boston Scientific, Medtronic

Research: Kestra, Inc; Biotronik; AtriCure

William G. Stevenson, MD

Officer, Trustee, Director, Committee Chair, or Any Other Fiduciary Role: American Heart Association

Intellectual Property Rights: Brigham and Women's Hospital, Biosense Webster, Inc.

Honoraria/Speaking/Consulting Fee; Abbott

Gordon F. Tomaselli, MD, FHRS

Consultant: Amgen, Scientific Advisory Board

CME COMPLIANCE SUBCOMMITTEE DISCLOSURES

Samuel J. Asirvatham, MD, FHRS – Honoraria/Speaking/Consulting Fee: Boston Scientific Corp., BIOTRONIK, Medtronic, Inc., Abbott Laboratories. Intellectual Property Rights: AliveCor

Peter F. Aziz MD, FHRS – Nothing to disclose

Marcie G. Berger. MD. PhD, FHRS – Nothing to disclose

Hiroko Beck, MD, FHRS – Nothing to disclose

Scott C. Brancato, MD, FHRS – Nothing to disclose

Scott J. Cox, MS, PAC, CEPS, CCDS – Compensation for Services; ScottCare Inc., Speaker's Bureau; Abbott.

Sandeep K. Goyal, MD, FHRS – Compensation for Services; Biosense Webster, Inc.

Peter A. Noseworthy, MD, FHRS – Nothing to disclose

Atul Prakash, MD, FHRS, CCDS, CEPS-A – Research Grants; BIOTRONIK

HEART RHYTHM STAFF DISCLOSURES

Laurel Blaydes – Nothing to disclose

Russell Werlinich – Nothing to disclose

Tonia Jones – Nothing to disclose

Almaz Aria – Nothing to disclose

Anne Marie Smith, MBA, PMP – Nothing to disclose

Timothy Gregory – Nothing to disclose

Obse Debela – Nothing to disclose